HNGE — Hinge Health, Inc.

Hinge Health Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $154 million, a 53% increase year-over-year.
• Last 12 Months (LTM) Calculated Billings: $624 million, up 50% from the previous year.
• Gross Margin: 83%, improved from 79% in Q3 2024.
• Operating Margin: 20%, a significant recovery from a negative 4% in Q3 2024.
• Free Cash Flow: $81 million, representing a free cash flow margin of 53%, compared to $28 million in Q3 2024.
• Cash Position: $497 million at the end of Q3, up from $415 million at the end of Q2.

2. Strategic Updates and Business Highlights

• Product Innovations: Introduction of AI initiatives like the AI care assistant "Robin" and automated movement analysis using TrueMotion Computer Vision technology.
• Member Growth: Surpassed 1.5 million lifetime members.
• Sales Momentum: 2,560 contracted clients, a 25% year-over-year increase, with expectations for further growth in Q4.
• HingeSelect Network: Launched with positive initial feedback; contracted with over 3,300 provider locations across all 50 states.
• Targeted Enrollment Initiatives: Significant improvement in member engagement, with targeted enrollment activities doubling compared to Q3 2024.

3. Forward Guidance and Outlook

• Q4 2025 Revenue Guidance: Expected to be between $155 million and $157 million, representing a 33% year-over-year growth at the midpoint.
• Full Year 2025 Revenue Guidance: Raised to $572 million to $574 million, indicating a 47% year-over-year growth.
• Operating Income Guidance for Q4: Projected between $34 million and $36 million, with a 22% margin at the midpoint.
• Full Year Operating Income Guidance: Expected between $106 million and $108 million, a significant increase from prior guidance.

4. Bad News, Challenges, or Points of Concern

• Seasonal Trends: Historically, Q4 is slower than Q3, which may lead to lower engagement and cash flow.
• Government Shutdown Risks: While current federal business remains strong, uncertainties exist if the shutdown extends beyond January 1, 2026, potentially impacting health benefits.
• Competitive Pressures: The company faces ongoing scrutiny from clients regarding ROI, especially as employer health care costs rise.

5. Notable Q&A Insights

• AI Adoption: Concerns about AI in healthcare are acknowledged, but Hinge Health emphasizes responsible AI development and transparency with partners.
• Open Enrollment Season: Clients typically launch new plans in Q1, with open enrollment serving as a promotional period rather than a direct enrollment opportunity.
• Yield and Engagement: The company expects yield to trend higher than previously anticipated, driven by ongoing targeted enrollment initiatives.
• HingeSelect's Impact: The integration of in-person care with digital solutions enhances Hinge Health's competitive advantage and client appeal.
• Future Investments: Continued investments in R&D and operational efficiencies are prioritized to maintain growth and improve margins.

Overall, Hinge Health demonstrated strong financial performance and strategic advancements in Q3 2025, while also navigating potential challenges and uncertainties moving forward.